Does hexarelin protect the heart?

Cardioprotective effects have been observed in preclinical and mechanistic research, described as acting through a pathway separate from its growth hormone release, which is why it is discussed differently from other secretagogues in this family. That is a description of what has been studied, not a demonstrated clinical benefit in a heart patient, and this site's evidence review found no large human trial establishing that effect at a specific dose.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of growth hormone secretagogues. Sermorelin, tesamorelin, ipamorelin, CJC-1295, and the rest of the GHRH and ghrelin receptor family.